D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ELVN holding history
Enliven Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELVN overviewAll 13F holders of ELVNFull Q2 2026 holdings
- Shares (Q2 2026)
- 305,703
- Value
- $15.5M
- % of portfolio
- <0.1%
- Quarters held
- 4
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 305,703 | $15.5M | <0.1% | +112,172+58.0% | Added | Holders |
| Q1 2026 | 193,531 | $7.59M | <0.1% | +193,531 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −83,866−100.0% | Sold out | Holders |
| Q4 2021 | 83,866 | $189.0K | <0.1% | +21,875+35.3% | Added | Holders |
| Q3 2021 | 61,991 | $253.0K | <0.1% | +61,991 | New | Holders |